PAS
THC icon

Park Avenue Securities’s Tenet Healthcare THC Stock Holding History

Park Avenue Securities’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
5,458
+1,827
+50% +$336K 0.01% 945
2026
Q1 		$685K Sell
3,631
-59
-2% -$12.4K 0.01% 969
2025
Q4 		$733K Sell
3,690
-289
-7% -$58.4K 0.01% 937
2025
Q3 		$808K Sell
3,979
-22
-0.5% -$3.9K 0.01% 970
2025
Q2 		$704K Sell
4,001
-7,374
-65% -$1.11M 0.01% 912
2025
Q1 		$1.53M Sell
11,375
-2,815
-20% -$371K 0.02% 469
2024
Q4 		$1.79M Buy
14,190
+1,837
+15% +$273K 0.02% 521
2024
Q3 		$2.05M Sell
12,353
-3,451
-22% -$522K 0.02% 421
2024
Q2 		$2.1M Buy
15,804
+2,549
+19% +$307K 0.03% 401
2024
Q1 		$1.39M Buy
13,255
+978
+8% +$87.9K 0.02% 523
2023
Q4 		$928K Buy
12,277
+384
+3% +$24.3K 0.01% 648
2023
Q3 		$784K Buy
11,893
+384
+3% +$28.7K 0.01% 663
2023
Q2 		$937K Buy
11,509
+1,307
+13% +$93K 0.01% 499
2023
Q1 		$606K Buy
+10,202
New +$567K 0.01% 569

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Park Avenue Securities's THC Position: Q2 2026 in Review

Park Avenue Securities increased its Tenet Healthcare (THC) stake by 50% in Q2 2026, buying an estimated $336K and bringing the position to 5,458 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #945.

Park Avenue Securities first reported a position in THC in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.1M in Q2 2024. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Park Avenue Securities held 5,458 shares of Tenet Healthcare worth $1.02M as of Q2 2026.
  • Park Avenue Securities bought 1,827 Tenet Healthcare shares in Q2 2026, an estimated $336K.
  • Tenet Healthcare made up 0.01% of Park Avenue Securities's portfolio in Q2 2026, its #945 holding.
  • Park Avenue Securities first reported a position in Tenet Healthcare in Q1 2023 and has held it in 14 quarters since.
  • Park Avenue Securities's Tenet Healthcare position peaked at $2.1M in Q2 2024.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.